
GT Biopharma, Inc.
USD0.36
+0.02 (+5.07%)
CEO
Michael Martin Breen
IPO Date
2018-03-27
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.35
Prev. Close
$0.34
Day Low
$0.34
Day High
$0.37
52W Low
$0.26
52W High
$2.29
Market Cap
$0.00B
Volume
0.47M
| 16 May 2023 |
| HC Wainwright & Co. |
| Buy |
| Buy |
| maintain |
| 15 May 2023 | EF Hutton | Hold | Hold | maintain |
| 3 Apr 2023 | HC Wainwright & Co. | Buy | Buy | maintain |
| 31 Mar 2023 | EF Hutton | Hold | Hold | maintain |
| 5 Jan 2023 | EF Hutton | Hold | Hold | maintain |
| 12 Sept 2022 | HC Wainwright & Co. | Buy | Buy | maintain |
| 24 May 2021 | HC Wainwright & Co. | Buy | Buy | maintain |